Navigation Links
Keystone Symposia Announces Grant from Alfred P. Sloan Foundation for an Advanced Life Sciences Training Program

SILVERTHORNE, Colo., April 16, 2013 /PRNewswire-USNewswire/ -- Keystone Symposia on Molecular and Cellular Biology is pleased to announce it has received a grant from the Alfred P. Sloan Foundation for a unique Advanced Life Sciences Training Program.

The grant will provide funding for a two-day conference in Denver in July 2013 for all five classes of participants in the Keystone Symposia Fellows Program since its inception in 2008. The Fellows Program is a high-level life science research mentoring and positioning program for postdoctoral fellows and other early-career investigators committed to diversity. Through involvement in the Keystone Symposia program development process, Fellows receive invaluable mentoring and access to the inner workings of the life sciences community. To date, 18 individuals have graduated from the Program, which is funded by a multi-year MARC (Minority Access to Research Careers) grant from the National Institute of General Medical Sciences of the NIH. Five participants are currently mid-way through the 2012-2013 Program.

The summer training conference will provide a face-to-face opportunity equipping participants with advanced grant-writing skills to increase the rate of grant acquisition for early-career scientists. It will also provide them with strategies and tools to confront diversity-related challenges and issues in the workplace. A variety of experts will be tapped from around the country to provide the training.

Dr. Laina King , Director of Diversity in Life Science Programs at Keystone Symposia, expressed her appreciation for the grant: "The support from the Foundation allows us to take the Fellows Program one step further and give participants formal and focused training in the areas that are proving most challenging for early-career investigators. We are deeply grateful for the commitment the Alfred P. Sloan Foundation is demonstrating to life science diversity in making such a program possible."

Dr. Elizabeth Boylan , Program Director at the Alfred P. Sloan Foundation, commented: "I am very pleased that we were able to make this grant as part of our higher-education portfolio focusing on professional advancement for underrepresented populations. We value the opportunity to assist early-career scientists in the acquisition of key professional skills, and look forward to learning about outcomes vis-a-vis standard career parameters as well as engagement with diversity matters on their home campuses and in their professional societies."

This is the second grant for Keystone Symposia from the Alfred P. Sloan Foundation. Some of Keystone Symposia's earliest diversity initiatives were launched with the help of a Sloan grant received in April 2008. Subsequent efforts have been funded with the help of the MARC grant as well as corporate support from Amgen, Biogen Idec and Novartis Institutes for BioMedical Research.

About Keystone Symposia
Keystone Symposia on Molecular and Cellular Biology, a 501(c)(3) nonprofit educational organization, has been conducting internationally renowned, open scientific conferences since 1972 and has been headquartered in Summit County, Colorado since 1990, when the organization left the University of California at Los Angeles. Annually, Keystone Symposia holds more than 50 conferences involving more than 12,000 scientists from around the world and on topics ranging from cancer and cardiovascular disease to neuroscience and plant biology. Registration fees are supplemented by support from corporate, foundation and individual donors as well as government grants.

More information on Keystone Symposia can be found at, and further details on its diversity initiatives and Fellows Program can be found at and respectively.

About the Alfred P. Sloan Foundation
The Alfred P. Sloan Foundation is a philanthropic, not-for-profit grantmaking institution based in New York City. Established in 1934 by Alfred Pritchard Sloan Jr. , then-President and Chief Executive Officer of General Motors, the Foundation makes grants in support of original research and education in science, technology, engineering, mathematics and economic performance. See for more information.

Yvonne M. Psaila
Director of Marketing & Communications
Keystone Symposia on Molecular & Cellular Biology
+ 1 970-262-2676 

Laina King
Director, Diversity in Life Science Programs
Keystone Symposia on Molecular & Cellular Biology
+ 1 970-262-2669

SOURCE Keystone Symposia on Molecular and Cellular Biology
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Heart Failure Society of America Annual Meeting To Feature Several Satellite Symposia
2. MiMedx Group, Inc. Announces Release Date for 2013 First Quarter Results
3. Arthritis Foundation Announces Appointment of John Vernachio As Vice President of Research
4. Taylor-Wharton™ Announces Recent Appointments in its Global Operations
5. Probiotic Action Announces an Acne Treatment that may Prevent and Reduce Redness and Irritation from Acne Breakouts
6. NeuroDerm Announces Enrollment in a Phase 2 Study of ND0612, a Continuous Levodopa/Carbidopa Drug for the Treatment of Parkinsons Disease
7. Veracyte Announces Appointment of Shelly D. Guyer as Chief Financial Officer
8. Probiotic Action Announces New Insight on Why Acne is a Problem for First World Citizens and Offers Advice on Treatments
9. Vestiage Announces Key Partners for Launch of Monterey Bay Nutraceuticals Anti-Aging Wellness Products
10. Probiotic Action Announces A New Natural Alternative to Expensive and harmful Acne Treatments
11. Rigaku Announces New EDXRF Method for Elemental Analysis in Gold Processing
Post Your Comments:
(Date:11/25/2015)... ANGELES and HOLLISTON, Mass. ... Technology, Inc. (Nasdaq: HART ), a biotechnology company ... that CEO Jim McGorry will present at ... December 1, 2015 at 2:30 p.m. PT. The presentation ... below) for 30 days. Management will also be available ...
(Date:11/25/2015)... , Nov. 25, 2015 /PRNewswire/ - Aeterna Zentaris ... that its business and prospects remain fundamentally strong ... Zoptrex™ (zoptarelin doxorubicin) recently received DSMB recommendation to ... completion following review of the final interim efficacy ... 2 Primary Endpoint in men with heavily pretreated ...
(Date:11/25/2015)... 25, 2015 Orexigen® Therapeutics, Inc. (Nasdaq: ... a fireside chat discussion at the Piper Jaffray 27th ... . The discussion is scheduled for Wednesday, December 2, ... .  A replay will be available for 14 days ... , Julie NormartVP, Corporate Communications and Business Development , ...
(Date:11/25/2015)... CA (PRWEB) , ... November 25, 2015 , ... ... genomics company uBiome, were featured on AngelList early in their initial angel funding ... an AngelList syndicate for individuals looking to make early stage investments in the ...
Breaking Biology Technology:
(Date:10/29/2015)... Oct. 29, 2015  Connected health pioneer, Joseph ... explosion of technology-enabled health and wellness, and the business ... The Internet of Healthy Things . ... smartphones even existed, Dr. Kvedar, vice president, Connected Health, ... care delivery, moving care from the hospital or doctor,s ...
(Date:10/27/2015)... Munich, Germany , ... (ASGM) automatically maps data from mobile eye tracking videos ... so that they can be quantitatively analyzed with SMI,s ... Germany , October 28-29, 2015. SMI,s Automated Semantic ... eye tracking videos created with SMI,s Eye Tracking ...
(Date:10/26/2015)... Oct. 26, 2015  Delta ID Inc., a company ... mobile and PC devices, announced its ActiveIRIS® technology powers ... NX F-02H launched by NTT DOCOMO, INC in ... the second smartphone to include iris recognition technology, after ... NX F-04G in May 2015, world,s first smartphone to ...
Breaking Biology News(10 mins):